Publications by authors named "Jesus G M Pariona"

Salmonella enterica subsp. enterica serovar Havana is a potential pathogenic serotype that can cause human foodborne illness. Therefore, we have conducted a microbiological and genomic surveillance study of Salmonella Havana from food in Brazil.

View Article and Find Full Text PDF

Background: Klebsiella pneumoniae producing KPC variants conferring resistance to ceftazidime-avibactam often remain susceptible to meropenem, suggesting a potential therapeutic use of this antibiotic.

Objectives: In this study, the efficacy of clinically relevant concentrations of meropenem was evaluated against high-risk clones of ceftazidime-avibactam-resistant K. pneumoniae strains producing KPC variants, in a tandem in vitro time-kill/in vivo Galleria mellonella survival model.

View Article and Find Full Text PDF

strains that produce Carbapenemase (KPC) variants displaying resistance to ceftazidime-avibactam (CZA) often remain susceptible to meropenem (MEM), suggesting a potential therapeutic use of this carbapenem antibiotic. However, studies indicate that these sorts of strains can mutate becoming MEM-resistant, raising concerns about the effectiveness of carbapenems as treatment option. We have studied mutation rates occurring from the reversion of MEM-susceptible KPC-114 to MEM-resistant KPC-2, in CZA-resistant belonging to ST11.

View Article and Find Full Text PDF

In this study, rapid diagnostic of multidrug-resistant (MDR) sepsis pathogens, directly from positive blood culture (BC) bottles, was evaluated by combining MALDI-TOF and the EUCAST Rapid Antimicrobial Susceptibility Testing (RAST). Carbapenemase production in Escherichia coli and Klebsiella pneumoniae isolates was also evaluated by RAST. From 171 positive BC bottles analyzed, 79 (46 %) MDR species, including E.

View Article and Find Full Text PDF
Article Synopsis
  • - Two new variants of carbapenemase, named KPC-113 and KPC-114, were discovered in clinical samples in Brazil in 2020, linked to resistance against the antibiotic ceftazidime-avibactam (CZA).
  • - KPC-113 and KPC-114 were found in different bacterial strains, with specific genetic mutations that contribute to their resistance profiles, showcasing a worrying trend in antibiotic resistance in South America.
  • - The emergence of these novel KPC variants poses significant challenges for treatment, highlighting the need for ongoing monitoring and surveillance of antibiotic resistance in the region.
View Article and Find Full Text PDF